The coolest place on the internet, according to this tagline.

November 18, 2011

FDA decides against blockbuster breast-cancer drug Avastin

  • what A blockbuster drug for breast cancer, Avastin, lost its FDA approval to be used for that particular purpose. (It will remain on the market as a cancer drug for other uses — including colon cancer — and Medicare will still cover it for breast cancer usage.)
  • why Multiple studies have shown that the drug only helps shrink tumors a little bit, and the side effects don’t make up for that benefit, the FDA decided. The decision means that many insurance providers will likely no longer cover the drug, which is very expensive. source

Read ShortFormBlogFollow

13:04 // 2 years ago
June 30, 2011

FDA decides against controversial breast cancer drug

  • 6-0 vote to take the breast cancer indication off Avastin source

» Even though lots of people liked the drug, the FDA has decided that it shouldn’t be used to treat breast cancer. However, European regulators allowed its use (as long as it was with another drug) at essentially the same time — which begs the question, why would the FDA be taking a drug off the market that so many people felt so passionate about?

Read ShortFormBlogFollow

14:05 // 3 years ago
June 28, 2011
Avastin saved my life…The studies are saying, they’re saying that people didn’t live for more than five months, you know. And there has to be other people like me that it works on.
Kerry Harrington, a breast cancer survivor • Arguing for the case for Avastin, a drug still being tested that treats breast cancer. The drug received accelerated approval for treating breast cancer, but now the FDA is backing away from allowing the drug for breast cancer treatment. This is mainly because Avastin has some pretty horrible side effects, like heart attacks and kidney damage. Many women are saying that the pros outweigh the cons — they’d rather deal with the side effects and know they’re treating their cancer. The FDA will decide after they hear testimony from patients and review other official data. source (viafollow)
13:50 // 3 years ago